F&C Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

F&C Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	$6.26M	Buy	120,451 +7,843	+7%	+$417K	0.08%	297
2013 Q4	$5.99M	Buy	112,608 +2,136	+2%	+$109K	0.07%	309
2013 Q3	$5.11M	Sell	110,472 -16,130	-13%	-$708K	0.07%	322
2013 Q2	$5.66M	Buy	+126,602	New	+$5.5M	0.08%	311

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

F&C Asset Management's BMY Position: Q1 2014 in Review

F&C Asset Management increased its Bristol-Myers Squibb (BMY) stake by 7% in Q1 2014, buying an estimated $417K and bringing the position to 120,451 shares worth $6.26M. The position accounts for 0.08% of the portfolio, ranked #297.

F&C Asset Management first reported a position in BMY in Q2 2013 and has held it in 4 quarters since. 1,327 funds tracked by Wall St. Rank hold BMY as of Q1 2014.

F&C Asset Management held 120,451 shares of Bristol-Myers Squibb worth $6.26M as of Q1 2014.
F&C Asset Management bought 7,843 Bristol-Myers Squibb shares in Q1 2014, an estimated $417K.
Bristol-Myers Squibb made up 0.08% of F&C Asset Management's portfolio in Q1 2014, its #297 holding.
F&C Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 4 quarters since.
1,327 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2014.

Based on F&C Asset Management's 13F filing for Q1 2014, filed 14 May 2014.